A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer.

Details

Language :

English

ISSN :

15560864

Volume :

7

Issue :

2

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

108220652

Full Text :

https://doi.org/10.1097/JTO.0b013e31823c5b11